# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.
An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Oral Simufila...
The credibility of the clinical trial results for an experimental Alzheimer's drug has been called into question following ...
On Monday, the U.S. stock market presented a mixed performance. The Dow Jones index managed to turn higher, trading up by 0.12%...
HC Wainwright & Co. analyst Vernon Bernardino reiterates Cassava Sciences (NASDAQ:SAVA) with a Buy and maintains $124 pr...
Cassava Sciences (NASDAQ:SAVA) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0....
The top-line results showed no decline in cognition scores in patients with mild Alzheimer's disease who received simufilam...